Difficulty: Medium
Average Score: 64%
Practice
Mechanism of Rifampin action is:
Correct answer
B
Rationale
The correct answer is B) Inhibition of DNA dependent RNA polymerase.
Rifampin is an antibiotic commonly used to treat tuberculosis and other bacterial infections. It exerts its bactericidal effect by specifically inhibiting the activity of bacterial DNA-dependent RNA polymerase. By targeting this enzyme, Rifampin disrupts the transcription process in bacteria, leading to the inhibition of RNA synthesis and ultimately impairing protein production, which is crucial for bacterial survival and replication.
Option A, inhibition of mycolic acids synthesis, is incorrect because Rifampin does not target the synthesis of mycolic acids, which are specific to the cell walls of mycobacteria like tuberculosis.
Option C, inhibition of topoisomerase II, is incorrect as Rifampin does not interfere with the activity of topoisomerase II, which is a target of other antibiotics like fluoroquinolones.
Option D, inhibition of cAMP synthesis, is also incorrect because Rifampin does not affect the synthesis of cyclic adenosine monophosphate (cAMP); its mechanism of action is specifically related to RNA polymerase inhibition.
Understanding the mechanism of action of Rifampin is crucial for healthcare professionals as it informs proper prescribing practices and helps in optimizing treatment outcomes while minimizing the risk of antibiotic resistance development.
Rifampin is an antibiotic commonly used to treat tuberculosis and other bacterial infections. It exerts its bactericidal effect by specifically inhibiting the activity of bacterial DNA-dependent RNA polymerase. By targeting this enzyme, Rifampin disrupts the transcription process in bacteria, leading to the inhibition of RNA synthesis and ultimately impairing protein production, which is crucial for bacterial survival and replication.
Option A, inhibition of mycolic acids synthesis, is incorrect because Rifampin does not target the synthesis of mycolic acids, which are specific to the cell walls of mycobacteria like tuberculosis.
Option C, inhibition of topoisomerase II, is incorrect as Rifampin does not interfere with the activity of topoisomerase II, which is a target of other antibiotics like fluoroquinolones.
Option D, inhibition of cAMP synthesis, is also incorrect because Rifampin does not affect the synthesis of cyclic adenosine monophosphate (cAMP); its mechanism of action is specifically related to RNA polymerase inhibition.
Understanding the mechanism of action of Rifampin is crucial for healthcare professionals as it informs proper prescribing practices and helps in optimizing treatment outcomes while minimizing the risk of antibiotic resistance development.